| Medical and Health Sciences | Lifetime | 891 | US 456 | 99.96 |
| Medical and Health Sciences | 2021-2025 | 646 | US 221 | 99.86 |
| Public, Environmental and Occupational Health | Lifetime | 23 | US 16 | 99.97 |
| Infectious Diseases | Lifetime | 47 | US 24 | 99.83 |
| Immunology | Lifetime | 279 | US 144 | 99.32 |
| Immunology and Allergy | Lifetime | 752 | US 307 | 83.20 |
| Infectious Diseases | 2021-2025 | 8 | US 4 | 99.84 |
| Public, Environmental and Occupational Health | 2021-2025 | 71 | US 26 | 99.44 |
| Immunology | 2021-2025 | 109 | US 38 | 97.84 |
| Mosquito-borne diseases and control | Lifetime | 3 | US 1 | 99.98 |
| Viral Infections and Vectors | Lifetime | 3 | US 1 | 99.97 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 18 | US 5 | 99.87 |
| interferon and immune responses | Lifetime | 8 | US 6 | 99.89 |
| COVID-19 Clinical Research Studies | Lifetime | 31 | US 8 | 99.79 |
| Viral Infections and Outbreaks Research | Lifetime | 28 | US 19 | 99.53 |
| Malaria Research and Control | Lifetime | 65 | US 17 | 99.63 |
| Virology and Viral Diseases | Lifetime | 73 | US 43 | 99.09 |
| COVID-19 Impact on Reproduction | Lifetime | 68 | US 29 | 97.81 |
| Complement system in diseases | Lifetime | 203 | US 82 | 97.80 |
| HIV Research and Treatment | Lifetime | 651 | US 391 | 98.41 |
| SARS-CoV-2 detection and testing | Lifetime | 281 | US 73 | 95.26 |
| Immune responses and vaccinations | Lifetime | 136 | US 38 | 95.15 |
| RNA regulation and disease | Lifetime | 538 | US 242 | 95.76 |
| Insect symbiosis and bacterial influences | Lifetime | 403 | US 158 | 96.53 |
| vaccines and immunoinformatics approaches | Lifetime | 788 | US 347 | 92.66 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 6 | US 4 | 99.90 |
| COVID-19 Clinical Research Studies | 2021-2025 | 16 | US 5 | 99.84 |
| Mosquito-borne diseases and control | 2021-2025 | 11 | US 3 | 99.52 |
| Virology and Viral Diseases | 2021-2025 | 3 | US 1 | 98.28 |
| Viral Infections and Vectors | 2021-2025 | 16 | US 5 | 99.22 |
| Viral Infections and Outbreaks Research | 2021-2025 | 20 | US 10 | 98.30 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 168 | US 64 | 96.06 |
| Immune responses and vaccinations | 2021-2025 | 22 | US 7 | 96.23 |
| SARS-CoV-2 detection and testing | 2021-2025 | 289 | US 73 | 94.39 |
| Animal Virus Infections Studies | 2021-2025 | 253 | US 63 | 93.59 |
| interferon and immune responses | 2021-2025 | 184 | US 39 | 92.47 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 555 | US 177 | 92.33 |
| Viral Infections and Immunology Research | 2021-2025 | 595 | US 144 | 86.36 |
| Zoonotic diseases and public health | 2021-2025 | 510 | US 138 | 81.19 |
| vaccines and immunoinformatics approaches | 2021-2025 | 634 | US 154 | 79.21 |
| Complement system in diseases | 2021-2025 | 518 | US 129 | 78.77 |
